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Background: Onchocerciasis caused by Onchocerca volvulus is the world’s second leading infectious cause of
blindness. There is currently no cure for the disease. Ivermectin, the current drug of choice is only microfilaricidal
and suboptimal response to it is increasingly being reported. Thus, in contributing to the search for a cure, crude
extracts and chromatographic fractions of Craterispermum laurinum and Morinda lucida were screened in vitro,
against the bovine and most popular model of the parasite, Onchocerca ochengi.
Methods: Extracted parasites were cultured in RPMI-1640 based media for 05 days in the presence of control drugs,
test drugs or drug diluents only. Microfilarial motility was scored using microscopy while adult worm viability was
determined biochemically by MTT/formazan colorimetry. Cytotoxicity and acute toxicity of active fractions were
tested on monkey kidney epithelial cells (LLCMK2) and in Balb/c mice, respectively.
Results: Out of the 18 extracts screened, the methanolic extracts of the leaves of both plants recorded the highest
activities against both the microfilariae (IC100 of 125 μg/ml for both extracts) and adult worms (IC100 of 250 μg/ml
and 500 μg/ml for M. lucida and C. laurinum respectively). The most active chromatographic fraction was obtained
from M. lucida and had an IC50 of 7.8 μg/ml and 15.63 μg/ml on microfilariae and adult worms respectively, while
the most active fraction from C. laurinum had an IC50 of 15.63 μg/ml and 46.8 μg/ml, respectively on microfilariae
and adult worms. The 50% cytotoxic concentration (CC50s) on LLCMK2 cells ranged from 15.625 μg/ml to 125 μg/ml
for the active fractions. No acute toxicity was recorded for the extracts from both plants. Phytochemical analysis of the
most active fractions revealed the presence of sterols, alkaloids, triterpenes, saponins and flavonoids.
Conclusions: This study validates the use of these plants by traditional health practitioners in managing the disease,
and also suggests a new source for isolation of potential lead compounds against Onchocerca volvulus.
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Human onchocerciasis (river blindness) caused by the fil-
arial worm, Onchocerca volvulus is one of the neglected
tropical diseases of major public health concerns [1]. The
disease is the world’s second leading infectious cause of
blindness with over 37 million patients and a risk popula-
tion of over 120 million [2]. Hyper endemic villages can
have infection rates of close to 100%, where up to 10% of
an entire village may be blind due to the disease. Close to* Correspondence: fidelis.ngwa@fulbrightmail.org
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unless otherwise stated.99% of all patients live in Tropical Africa [3,4]. Pathologic-
ally, the disease is associated with extensive and disfigur-
ing skin changes, musculoskeletal complaints, weight loss,
and changes in the immune system [5]. In addition to its
severe pathological effect, it causes grave socio-economic
problems and life-long human suffering [6].
Two major strategies employed in the control of on-
chocerciasis are mass treatment of infected people with
ivermectin and the elimination of the Simulium vector
[7,8]. Despite the successes registered in reducing the
disease burden, total elimination has not been achieved
due to pitfalls in the control programmes. At present,
only ivermectin (Mectizan®, Merck) is recommended fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Samje et al. BMC Complementary and Alternative Medicine 2014, 14:325 Page 2 of 12
http://www.biomedcentral.com/1472-6882/14/325chemotherapy and for mass drug administration. Al-
though this drug has been shown to significantly reduce
transmission of the disease, its filaricidal effect is limited
only on the juvenile form of the parasite [9,10]. Studies
have revealed that treatment of some Onchocerca pa-
tients with ivermectin who are co-infected with Loa loa
may result in adverse effects, which ranged from fatigue
to consciousness disorders and death [11,12]. Therefore,
the ideal drug for onchocerciasis would be inactive against
the microfilariae of Loa loa. Suboptimal response to iver-
mectin has also been reported in different studies [13-16].
Thus, the search for new, safe and efficacious onchocer-
ciasis drugs is imperative.
Herbal medications play a central role in the cure of sev-
eral diseases particularly in developing countries [17,18]. In
some Asian and African countries, 80% of the population
depends on traditional medicine for primary health care,
and herbal medicines are the most lucrative form of trad-
itional medicine, generating billions of dollars in revenue
[19]. The anti-filarial activities of some plant extracts
have been documented [20-23].M. lucida and C. laurinum
(family: Rubiaceae) have been shown to express anti-
bacterial activity on a range of bacteria [24,25]. Other
separate studies have revealed that M. lucida possess
anti-plasmodial activity [26], suppressed Trypanosoma
brucei parasites [27] and have hypoglycaemic activity
[28]. Onchocerca ochengi, found exclusively in cow is the
closest relative to the medically important O. volvulus.
Similarities lie in them sharing the same vector, their
microfilariae being equally sensitive to ivermectin and
their adult worms found in the sub-cutaneous/intradermal
nodules [29]. Since the bovine parasite species is relatively
more abundant in Africa and also cheap to obtain, it is
thus a model of choice in anti-onchocercal drug
screens. In an attempt to contribute to anti-onchocercal
lead development, we herein report on in vitro filaricidal
properties of both crude extracts and chromatographic
fractions of extracts of C. laurinum and M. lucida against
Onchocerca ochengi parasite stages. Additionally, we re-
port on the cyto- and acute toxicity profiles of the best ex-
tracts and fractions of the two plants, thereby initiating a
novel lead compound discovery endeavour.
Methods
Collection and identification of plant materials
Various plant parts (leaves, barks and roots) of C. lauri-
num were collected from Finge village of the Bambui
Health District in the North West Region of Cameroon
in June 2010, while M. lucida plant parts were collected
from Buea at the foot of Mount Fako, Cameroon in
January 2011. The plants were selected based on ethno-
pharmacological information about them. The plants
were identified and authenticated by Mr. Paul Mezili of
the National Herbarium, Yaounde, Cameroon and giventhe voucher number (Poir) Benth No 3781/SRFK for
C. laurinum and Benth No 2615/SRFK for M. lucida.
Locally, C. laurinum is called “sarkaatari”.
Preparation of crude extracts and chromatographic
fractions
All the plant parts collected were air dried, then ground
to fine powder. The ground materials were weighed and
sequentially submerged and macerated for a total of
72 hours in three solvents thus: hexane (HEX), methy-
lene chloride (MC), and methanol (MeOH). For each
solvent, the maceration was repeated twice. The mixture
was filtered and the filtrate concentrated using a rotary
evaporator (BUCHI Rotavapor R-200, Switzerland) at ap-
propriate temperatures. The concentrate were recovered
with methylene chloride and allowed to stand open at
room temperature until all the residual solvents had
evaporated. The dried crude extracts were stored at −20°C
until needed for the assays.
Bioassay-guided fractionation was done on the most
active crude extracts. Each of the latter extract was fixed
on celite and fractionated using vacuum liquid chroma-
tography on silica gel and then eluted with a continuous
gradient of ethyl acetate (EtOAc [0–80%]) in hexane,
followed with a gradient of methanol (MeOH [0-40%])
in methylene chloride. Collected fractions were pooled
on the basis of their thin layer chromatographic (TLC)
profiles.
Isolation and culture of O. ochengi adult worms
(macrofilariae)
This was done by the method of Cho-Ngwa et al. [22]
with slight modifications. Briefly, fresh pieces of umbil-
ical cattle skin containing large amount of palpable nod-
ules were brought from local slaughterhouses to the
laboratory. The skin was thoroughly washed successively
with tap and distilled water, drained and totally covered
with 70% ethanol which was allowed to evaporate on its
own in a laminar flow hood sterile environment. Pale
orange-yellow O. ochengi adult worm masses containing
essentially viable adult female and male worms were re-
covered by careful dissection of the nodules using sterile
razor blade. The extracted worms were immediately sub-
merged into complete culture medium (CCM) (RPMI-
1640 supplemented with 25 mM HEPES, 2 g/L sodium
bicarbonate, 20 mM L-glutamine, 10% new born calf
serum [SIGMA, USA], 200 units/ml penicillin, 200 μg/ml
streptomycin and 2.5 μg/ml amphotericin B [Sigma, USA],
pH 7.4) in 24 wells. The viability of worms was determined
by microscopic examination using an inverted microscope
(euromex, Holland). The cultures were incubated at 37°C
under an atmosphere of 5% CO2 in humidified air in
a HERACELL-150 CO2 incubator (Thermo Electron,
Germany) for 05 days post addition of drug.
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Fresh and cleaned infected cattle skin was sterilized as
above and tautly attached onto a sterile wooden board.
A portion of the skin was then carefully shaved with
razor blade, rinsed with distilled water and completely
covered with 70% ethanol. The ethanol was allowed to
evaporate freely and completely in a laminar flow hood.
The skin was then firmly attached onto an autoclaved
cylindrical piece of wood and close crisscross cuts of
about 0.5-1 mm apart were made into the epidermal and
dermal layers, over the entire skin surface. The entire as-
sembly was transferred into a sterilized glass cylinder
and an appropriate volume of CCM was added to just
cover the entire skin. The assembly was incubated for 4 –
6 hours at room temperature. The emergent and highly
motile microfilariae (mfs) were concentrated by centrifu-
gation (400 × g for 10 minutes) and quantified microscop-
ically. Then, 100 μl of CCM containing 15–20 mfs was
transferred into each well of a 96 well microtitre culture
plates. After addition of drugs, the mfs were cultured at
37°C under an atmosphere of 5% CO2 in humidified air
in a HERACELL-150 CO2 incubator (Thermo Electron,
Germany).
Preparation of mammalian cells for microfilarial cultures
and cytotoxicity assay
Monkey kidney epithelial cells (LLCMK2) purchased
from the American Type Culture Collection (ATCC,
Virginia, USA) was proliferated in complete culture
media at 37°C and 5% CO2. Once the cells became
fully confluent, the old media was decanted and the
cells were dislodged with 0.125% trypsin and 0.5 mM
EDTA in serum-free RPMI-1640 culture medium. The
dislodged cells were re-suspended in 10 mL of complete
culture medium and centrifuged at 560 × g for 10 minutes
to get rid of the trypsin. The last procedure was repeated
once. The cell suspension (100 μL/well) was transferred
into 96-well microtitre culture plates and kept in the CO2
incubator for cells to grow and become fully confluent,
usually taking 3–5 days depending on the initial concen-
tration of cells. LLCMK2 cells served as feeder layer for
mfs cultures and also for cytotoxicity studies. The selectiv-
ity index (SI) of each extract was calculated as the ratio of
CC50 of drug to these mammalian cells to the IC50 of the
drug on the parasites.
Preparation and in vitro screening of crude extracts and
fractions
A stock solution of 25 mg/ml crude extract in ≥99.9%
sterile dimethyl sulfoxide (SIGMA, USA) was prepared.
Adult worm assays were conducted in 24-well plates
(2 mL/well) (NUNC, USA) for 5 days without any
change of medium. On the other hand, all mfs-only as-
says were conducted in 96-well microtitre plates (200 μL/well) that contained confluent feeder layer of the mon-
key kidney cells. The media used in preparing the feeder
cell layer was removed by swift decantation before fresh
medium and worms for drug testing were added. Assays
were run for 5 days post-addition of extract without any
change of medium.
Primary screen for adult worm and microfilariae
This was done in order to eliminate inactive extracts.
Each extract was dissolved to 2X its final test concentra-
tion in CCM in a single sterile well before distribution
into replicate wells. In this regard, 1 ml per well or
100 μl per well for adult worm or mfs respectively, were
transferred into replicate culture wells, each already con-
taining either adult worm in 1 ml of CCM or mfs in
100 μl of CCM, to give a final volume of either 2 ml for
the adult worm assay or 200 μl for the mfs assay. The
crude extracts were tested in quadruplicate wells (for
adult worms) and in duplicate (for mfs) at a single con-
centration of 500 μg/mL. A compound (BTU55261)
known to be active (unpublished) was used as the posi-
tive control for the adult worm assay, while ivermectin
(IVM) was used as a positive control for the mfs assay.
BTU55261 produces 100% inhibition of formazan for-
mation in adult worms on day 5 at a concentration of
2.5 μg/ml, while IVM totally inhibits mfs motility at
10 μg/ml by day 5. Negative controls were treated in the
same way as the test samples, received the drug diluents
(≤2% DMSO in RPMI), but with no drug added.
Male worm motility inhibition was scored using an
inverted microscope and was recorded as 100% (complete
inhibition), 75% (only head or tail of worm moving or
vibrating), 50% (worm sluggish) or 25% (little change
in motility), 0% (no observable inhibition of motility).
Biochemical evaluation of adult worm viability was done
using the MTT/formazan colorimetric assay [30,31]. The
worms were placed under sterile conditions in a well of a
48-well plate containing 500 μL/well of 0.5 mg/mL MTT
(Sigma, USA) in serum free media and then incubated
under the culture conditions for 30 minutes. Thereafter,
the worms were blotted individually on tissue paper and
colour development of the test compared with the con-
trols. MTT, a pale yellow compound is reduced to a dark
blue product, formazan by the living cells of the worms.
Adult worm viability was taken as mean percent inhibition
of formazan formation relative to negative control at
120 hours post addition of drug. Inhibition of formazan
formation by extracts relative to the negative controls
showed that an extract was either active (90% or greater
mean inhibition of formazan formation), moderately ac-
tive (50 - 89% mean inhibition of formazan formation) or
inactive (<50% mean inhibition of formazan formation).
Viability of mfs was assessed by reading their mean motil-
ity scores every 24 hours (post addition of drug) for
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extract was considered active on the mf if there was a
100% reduction in mfs motility; moderately active if there
was a 50-99% mean reduction in mfs motility and inactive
if there was less than 50% mean inhibition of motility
compared to untreated controls of the same experiment.
Secondary screen
This was done in order to confirm the activity of extracts
that were promising in the primary screen, as well as to
determine the IC50 and selectivity index (SI) values. All
the active extracts that showed 100% macrofilaricidal and/
or microfilaricidal properties were re-tested as in the pri-
mary screens and at serial dilutions of 8 different concen-
trations starting from 500 μg/mL down to 3.91 μg/mL.
The graphical analysis was done using Microsoft Excel
2007 (Microsoft Corporation, USA).
Acute toxicity of active extracts in mice
The test was conducted following the European Commu-
nity Guidelines for protection of animals used for experi-
mental purposes [32] and respecting the 3Rs (Replacement,
Refinement and Reduction) of Animals in Research [33].
Currently, there is no law governing the use of Balb/C mice
for research purposes in Cameroon. Mice used in the study
were commercially gotten from Centre Pasteur, Yaoundé.
Nulliparous, non-pregnant 10 weeks old female Balb/c
mice were weighing 22.4 ± 1.5 g were randomly selected
and kept in their cages for 5 days before dosing [34]. The
test was done for the methanolic extracts of C. laurinum
and M. lucida as well as for fractions that demonstrated an
IC50 of ≤ 31.25 μg/ml on mfs. The equivalent of 5 times
IC50 of each substance was injected intraperitoneally into
separate groups of 6 mice while 6 control mice were
injected with an equal volume of diluent (2% DMSO in
normal saline). Briefly, considering the 5 × IC50s of
93.75 μg/ml for the C. laurinum extract, 10.3 mg of the ex-
tract was dissolved in 100% DMSO and then diluted in
normal saline such that the final DMSO concentration was
2%. The diluted extract was then injected into the chosen
mice. The same procedure was repeated for all the selected
active fractions. Following dosing, the animals were ob-
served every 30 minutes for the first 4 hours. Thereafter,
the physical activity, weight of food and the volume of
water consumed, changes in skin and fur, tremors, convul-
sions, diarrhea, sleep, coma and death were noted daily for
the 14 day study period.
Phytochemical analysis
Following screening, phytochemical derivatives found in
the most active fractions were investigated by standard
methods [35]. Briefly, the presence of alkaloid was deter-
mined using the Drangedoff ’s reagent while the presence of
sterols and triterpenes was determined by the LiebermannBuchard reaction. For the presence of flavonoids, the ex-
tract was dissolved in methanol and 2–3 mL of concen-
trated HCl was added. A spatula full of magnesium
turnings was then added and the mixture observed for
effervescence. The presence of saponins was determined
by dissolving a trace amount of the extract in water and
shaking thoroughly. Frothing which persisted on warming
was observed and taken as preliminary evidence. Test for
Tanins was done by adding 10 ml of distilled water to 2 g
of plant extract, stirred, filtered and ferric chloride later
added to the filtrate.
Results
Activity of crude extracts of both plants on adult worm
and microfilariae
A total of 18 crude extracts were prepared from the two
plants (9 from each) using solvents of different polarities
(hexane, methylene chloride and methanol). Results of
the primary screen showed that the methanol extracts of
the leaves of both plants had the highest anti-parasite
activity. By contrast, the methanol extracts of barks,
roots, as well as the hexane extracts and methylene
chloride extracts of both plants were inactive. Conse-
quently, further testing on these extracts was discontin-
ued. Table 1 summarizes the effect of the methanolic
extracts of both plants on adult worm and mfs.
The SIs of CLLMeOH and MLLMeOH on adult male
and female worms was 1 while those of CLLMeOH and
MLLMeOH on mf were respectively 2.6 and 2 and that
of ivermectin in the same experiment was 1.0. This
was not surprising since ivermectin kills Onchocerca
mfs in vitro within 5 days only at a much higher con-
centration relative to the therapeutic dose in humans.
Although there was 100% inhibition of mfs motility on
day 5 for extracts of both plants at 125 μg/ml, M. lucida
demonstrated more rapid activity in time-dependent
studies (Figure 1). Complete inhibition of motility
was observed with M. lucida by the 48th hour unlike
C. laurinum which showed full activity only at the
120th hour.
Activity of chromatographic fractions of C. laurinum on
microfilariae and adult worms
Nine fractions; A, B, C, D, E, F, G, H, I were sequentially
obtained and tested on both the juvenile and adult form
of the parasite. The first and last fractions (A and I) were
inactive on both the mfs and adult worms. The highest
activity on mfs (IC100 of 31.25 μg/ml and IC50 of
15.625 μg/ml) was observed with fraction G (Table 2).
Except for fractions B and H, there was 100% inhib-
ition of mfs motility by the 24th hour of culture in the
presence of the active fractions at the highest concen-
tration of 500 μg/ml. Four fractions (A, B, H and I)
showed no activity on the adult female worms. Out of




% inhibition of adult male
worm motility




CL LMeOH ML LMeOH CL LMeOH ML LMeOH CL LMeOH ML LMeOH
500 100 100 100 100 100 100
250 50 100 50 100 100 100
125 50 50 50 50 100 100
62.5 0 0 0 0 25 50
31.25 0 0 0 0 0 25
15.63 0 0 0 0 0 0
0 0 0 0 0 0 0
Positive control 100 100 100 100 100 100
Negative control 0 0 0 0 0 0
(CLLMeOH: methanolic extract of C. laurinum and MLLMeOH: methanolic extract of M. lucida).
Samje et al. BMC Complementary and Alternative Medicine 2014, 14:325 Page 5 of 12
http://www.biomedcentral.com/1472-6882/14/325these, Fraction H demonstrated moderate activity on
the adult male worms while the rest were inactive on
the male worms. Fraction E inhibited motility and for-
mazan formation in the male adult and female adult
worms respectively at the same concentration (Figure 2
a and b). A comparison of the IC50s of the adult worms
and mfs and the CC50s of the most active fractions is
shown in Figure 3.
Activity of chromatographic fractions from the methanol
extract of M. lucida on microfilariae and adult worms
One hundred and fifty fractions of 500 mL each were col-
lected using hexane:ethyl acetate and methylene chloride:
methanol eluent. The fractions were pooled on the basis
of their TLC profiles to give a total of seventeen combined




































Figure 1 Time-dependent inhibition of mfs motility at 125 μg/ml by tshowed moderate activity on mfs but were inactive on ei-
ther the adult male or female worms while the rest exhib-
ited full activity on mfs at a concentration of 500 μg/ml by
day 5. The dose-dependent result of the active fractions
on mfs by the 120th hour of culture is shown on Table 3.
Fraction MLM10 was the most active with an IC100 of
15.63 μg/ml and an IC50 of 7.8 μg/ml. Additionally, the
fractions also exhibited a time dependent inhibition of mfs
and adult male motility. Out of the 17 fractions, seven
showed activity on the adult worms (Figure 4a and b)
while 5 were moderately active. Only two of the seven ac-
tive extracts exhibited effect on both the male and female
worms at the same concentration. The general trend ob-
served for the seven most active fractions was that they
were all almost more active on the male adult worms and
mfs than their adult female counterpart (Figure 5). Figure 672th 96th 120th
ion (hours)
um M. lucida
he methanolic extract of M. lucida and C. laurinum.
Table 2 Chromatographic profile and activity of nine fractions of CLLMeOH on microfilariae motility
Eluent Combined
Fractions: code
% inhibition of microfilarial motility on day 5 concentration of extracts (μg/ml)
Hex:EtOAc 500 250 125 62.5 31.25 15.63 7.8 0 IC50 of mfs
100:0 1-14: A 0 0 0 0 0 0 0 0 /
90:10 15-20: B 100 50 0 0 0 0 0 0 250
80:20 21-28: C 100 100 100 0 0 0 0 0 93.5
70:30 29-39: D 100 100 25 25 0 0 0 0 187.5
60:40 40-60: E 100 100 75 50 25 0 0 0 62.5
40:60 61-67: F 100 100 100 100 75 50 0 0 15.63
CH2Cl2:MeOH
20:80 68-78: G 100 100 100 100 100 50 0 0 15.63
95:5 79-99: H 100 75 50 25 0 0 0 0 125
0:100 100-108: I 0 0 0 0 0 0 0 0 /
Hex: hexane, EtOAc: ethyl acetate, TLC: thin layer chromatography, CH2Cl2: methylene chloride, MeOH: methanol.
a
b
Figure 2 Percent killing of male adult worms (a) and female adult worms (b) by active fractions from C. laurinum.
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male adult worms female adult worms microfilariae CC50
Figure 3 IC50s and CC50s of most active fractions of C. laurinum on respectively mfs, adult worms and LLCMK2 cells.
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adult worms by fraction MLM11. This dose-dependent
disparity in the conversion of MTT to formazan is a re-
flection of adult worm viability.
Cytotoxicity and acute toxicity of active extracts
Cytotoxicity was determined for all the crude extracts
and chromatographic fractions, while acute toxicity wasTable 3 Chromatographic profile and activity of seventeen fr
Eluent Combined
Fractions:code
% inhibition of microfilariae mo
Hex:EtOAc 500 250 125 62
100:0 1-13: MLM1 100 50 0 0
95:5 14-16: MLM2 50 0 0 0
17-24: MLM3 100 100 50 0
90:10 25-32: MLM4 50 0 0 0
80:20 33-40: MLM5 100 75 0 0
41-49: MLM6 50 25 0 0
70:30 50-54: MLM7 100 75 50 0
55-61: MLM8 100 100 100 50
60:40 62-65: MLM9 100 100 100 10
66-74: MLM10 100 100 100 10
50:50 75-86: MLM11 100 100 100 10
40:60 87-100:MLM12 100 100 100 50
20:80 101-109:MLM13 100 100 100 10
110-117:MLM14 100 100 100 10
CH2Cl2:MeOH
95:5 118-120:MLM15 100 100 100 50
121-128:MLM16 75 50 25 0




MLM: M. lucida leaves. The 0 μg/ml are the negative control wells with 2% DMSO.done only for the most active extracts and fractions. For
the most active fractions of C. laurinum, the cytotoxic
concentration of the fractions on LLCMK2 cells ranged
from 15.125 μg/ml to 125 μg/ml (Figure 7a) while those
of fractions from M. lucida ranged from 15.625 μg/ml to
31.25 μg/ml (Figure 7b). The CC50s of the active frac-
tions for C. laurinum and M. lucida are respectively
shown on Figures 3 and 5. The SIs of the two activeactions from MLLMeOH on microfilariae motility
tility on day 5 concentration of extracts (μg/ml)
.5 31.25 15.63 7.8 0 IC50 of mfs
0 0 0 0 250
0 0 0 0 500
0 0 0 0 125
0 0 0 0 500
0 0 0 0 187.5
0 0 0 0 500
0 0 0 0 125
25 0 0 0 62.5
0 50 0 0 0 31.25
0 100 100 50 0 7.8
0 50 50 25 0 15.63
0 0 0 0 62.5
0 100 25 0 0 23.44
0 50 0 0 0 31.25
25 25 25 0 62.5
0 0 0 0 250
0 0 0 0 250
ab
Figure 4 Percent killing of male adult worms (a) and female adult worms (b) by active fractions from M. lucida.
Figure 5 IC50s and CC50s of active fractions of M. lucida on mfs, adult worms and LLCMK2 cells.
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Figure 6 Variation in the conversion of MTT salt to formazan
by adult female worms.
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imals for acute toxicity were monitored daily for changes
in physical activities and appearance. Immediately fol-
lowing administration of the test substances, the animals
displayed signs of discomfort and feebleness which lasted
only for few minutes. By the first observation (30 minutes
after dosing), the animals were already agile. For the four-
teen days study period, none of the dosed mice died.
When compared with their normal controlled counter-
parts, the intake of food and water was the same. There
was daily regular agility. No change was observed in the
physical activities and behavior in the test animal. Add-
itionally, there was no loss of fur, no change in skin and
mucous membrane. Visibly, the test and controlled groups
were indistinguishable from one another on basis of their
appearances and physical activity at the end of the 14 days
study period.
Phytochemical constituents of most active fractions
Only fraction MLM14 from M. lucida showed a positive
test for alkaloids. On the other hand, sterols were
present in all the active fractions of C. laurinum as well
as fractions MLM13 and MLM14 of M. lucida (Table 4).
Discussion
The primary aim of this study was to search in medi-
cinal plants for new filaricidal compounds that might
serve as drug leads. From ethnobotanical survey, two
plants, C. laurinum and M. lucida from the same family(Rubiaceae) were selected for study. Traditional health
practitioners in Finge, a small community in North West
Cameroon with high prevalence of onchocerciasis use
C. laurinum to manage the ailment. This plant showed
activity when screened in vitro against the bovine form
of the parasite, O. ochengi which is the closest relative
to the human form, O. volvulus. Based on the results
obtained with C. laurinum, we decided to extend the
study using a different member of the family, M. lucida
gotten from the foot of Mount Cameroon (a different
ecological setting). The results obtained from this study re-
vealed the presence of filaricidal activities in the two plants
that were obtained from two different geographical regions.
In separate studies, both plants have been reported to show
activites against Trypanosoma brucei brucei, a range of
bacterial species, Leishmania major and P. falciparum
[24-26,36]. Other studies carried out with Carapa procera,
Polyalthia suaveolens [21], Piliostigma thonningii, Ocimum
gratissimum, Nauclea latifolia and Alstonia boonei [37],
Homalium Africanum [22], Annona senegalensis, Anogeis-
sus leiocarpus, Euphorbia hirta, Parquetina nigrescens and
Khaya senegalensis [23] have demonstrated anti-Oncho-
cerca and anthelmintic activities.
The methanolic extracts of the leaves were the most
active of both plants. Traditionally, C. laurinum concoc-
tion is prepared by boiling the leaves of the plant in
water. Thereafter, a glass (~200 ml) of the resulting li-
quid is drunk three times a day for upto one month de-
pending on manifested signs and symptoms. The highest
activity recorded by the methanolic extracts partly justi-
fies the efficiency of this method of preparation of the
traditional regimen although the traditional preparations
are hardly standardized. In a different study [22], the
non-polar extracts of Homalium africanum were shown
to be more active than the polar extracts. Although
studies have shown that non-polar compounds such as
essential oils are nematocidal [38], we herein demon-
strate the nematocidal property of some polar extracts.
Ndjonka and others reported similar findings in which
the ethanolic extract from the leaves of Annona senega-
lensis killed O. ochengi worms [23]. Significant differ-
ences were observed in the IC50s of the crude extract
and their fractions. The IC50s of C. laurinum crude ex-
tract on mfs were 93.75 μg/ml and 15.625 μg/ml respect-
ively, for the crude extract and fraction G (fraction with
highest activity). The same observation was seen with
M. lucida extract which had IC50s of 62.5 μg/ml and
7.8 μg/ml for its crude extract and most active fraction
(MLM 10) respectively. In like manner, IC50s of adult
worms varied considerably with the derived fractions
and the stock crude extracts. For both plants, the IC50s
of the most active fractions were at least three fold lower
than that of the extract. At present, we are investigating
and characterizing the bioactive compounds responsible
ab
Figure 7 % cytotoxicity of most active fractions of C. laurinum (a) and M. lucida (b) on LLCMK2 cells.
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http://www.biomedcentral.com/1472-6882/14/325for the observed filaricidal activity. It is likely that fol-
lowing purification, some compounds will be obtained
that will demonstrate activity that is higher than those
gotten from their fractions.
Activity varied between the stages of the parasite and
the extract/fraction used. While some extracts/fractionsTable 4 Phytochemical analysis of the most active fractions
Most active fractions from C. laurinum
Active substance C D E F G
Alkaloids - - - - -
Sterols + + + + +
Triterpenes - - - - -
Saponins - - - - -
Tannins - - - - -
Flavonoids - - - - -exerted more activity on the male adult worms, some
showed more activity on the female and others still dem-
onstrated more efficiency only on the mfs. The fractions
also demonstrated a dose- and time-dependent activity
with efficacy increasing when the dose was increased
and the time of incubation also extended. DiscrepancyMost active fractions from M. lucida
H MLM9 MLM10 MLM11 MLM13 MLM14
- - - - - +
+ + - - + +
- - + + - -
- - - - - +
- - - - - -
- + - - + +
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probably indicates a variation in the target of the differ-
ent extracts. However, all the extracts/fractions that were
either active or moderately active on adult worm also
showed activity on microfilariae. The reverse was not al-
ways true. This juvenile form of the parasite is appar-
ently more susceptible to the extracts than their adult
worm counterpart. Ivermectin exerts a similar selective
effect. One fraction from C. laurinum (fraction E) had
the same IC50 (62.5 μg/ml) for all the three forms of the
parasite. This was in contrast to the rest of the fractions
where IC50s for mfs were generally lower than IC50s of
adult worms. These interesting findings give more opti-
misms in the Onchocerca drug search as the drug of
choice for the treatment of onchocerciasis should be one
that possesses both macro-/microfilaricidal activity.
The studied plants showed no overt toxicity in labora-
tory mice. Regular food and water intake by all the mice
was not hampered during the fourteen day period of
follow-up. The apparent weakness and discomfort no-
ticed immediately after dosing was probably a result of
shock that came about by the consecutive use of 70% al-
cohol (for disinfecting the site of administration) and in-
jection. Contrary to this observation, the most active
extracts/fractions were apparently cytotoxic to LLCMK2
cells in the in vitro assay. The SI values for both the
methanolic extracts of M. lucida and C. laurinum were
1.52 μg/ml and 2.67 μg/ml respectively while that of the
control drug; ivermectin was 1 μg/ml. This finding sug-
gests that cytotoxicity of an extract/compound might
not necessarily imply in vivo toxicity. This finding is con-
sistent with the observations on Homalium africanum
and Margaritaria discoidea [22]. A detoxification mech-
anism may account for this in vivo observation and also
partly justifies the absence of adverse effects in patients
who take the concoction for therapy.
Conclusion
This study has revealed the anti-Onchocerca activities of
extracts of M. lucida and C. laurinum, indicating a pos-
sible new source for developing a phytomedicine or drug
for the treatment of the disease. It also validates the use
of C. laurinum by traditional health practitioners in the
management of the disease in rural areas where oncho-
cerciasis is prevalent.
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